News Features Funding the Future: How Industry Support for CV Trials Could Evolve Michael O'Riordan December 17, 2020
News Conference News AHA 2020 No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk Michael O'Riordan November 19, 2020
News Daily News More Teamwork, Coordination Could Boost CV Studies in COVID-19 Shelley Wood October 28, 2020
News Daily News Uptick in Heparin-Induced Thrombocytopenia in COVID-19 Complicates Care Michael O'Riordan October 02, 2020
News Daily News As Interventions Dip During COVID-19, CMS Offers Leniency on Volumes Todd Neale September 23, 2020
News Daily News Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD Michael O'Riordan September 22, 2020
News Conference News ESC 2020 ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA Michael O'Riordan September 01, 2020
News Daily News Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19 Michael O'Riordan August 28, 2020
News Daily News Too Many HF Trial Results Underreported or Never Published L.A. McKeown June 23, 2020
News Daily News Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension L.A. McKeown June 08, 2020
News Daily News Even Very Sick Kids Fare Well Despite Kawasaki-Like COVID-19 Symptoms Todd Neale May 21, 2020
News Features Cardiology After COVID-19: Physicians Predict Lasting Change Yael L. Maxwell May 20, 2020
News Opinion Off Script COVID-19 Begs the Question: If Medical Meetings Go Virtual, What Do We Gain and Lose? Asif Qasim, MB BChir, PhD March 06, 2020
News Features Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology Michael O'Riordan March 03, 2020
News Daily News Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA Michael O'Riordan January 21, 2020